Karin Rexroad peeks through the bore of the PET-CT scanner at LMH Health. Positron emission tomography, or PET, scans have long been used to diagnose cancer and determine how far it has progressed.

Margin distance as an independent predictor of survival after R0 resection for pancreatic adenocarcinoma. Background: The role of fusion positron emission tomography/computed tomography scans (PET/CT) ...

DUBLIN--(BUSINESS WIRE)--The "Positron Emission Tomography (PET) Scanners - A Global Market Overview" report has been added to ResearchAndMarkets.com's offering. The global market for Positron ...

The evaluation of radiation dose in positron emission tomography (PET) is an essential component of modern nuclear medicine. Accurate dosimetric assessment ensures that the diagnostic benefits of PET ...

Positron emission tomography (PET) remains a cornerstone of biomedical imaging, offering a non‐invasive technique to visualise metabolic processes and molecular pathways in vivo. Central to the ...

We surveyed oncologists who treat classic Hodgkin lymphoma (cHL) as part of the CONNECT study to understand the treatment decision‐making process, including the impact of positron emission ...

Positron emission tomography (PET) is a type of imaging scan that doctors might use when diagnosing and treating non-Hodgkin’s lymphoma (NHL). It can be useful for identifying and staging the cancer.

A new study from Brigham and Women's Hospital suggests that positron emission tomography (PET) brain scans could reveal hidden inflammation in patients with multiple sclerosis (MS) who are being ...

Positron emission tomography (PET) scans can detect cancer earlier than other imaging tests. But some types of cancer are harder to detect on a PET scan. In particular, they may miss cancers that ...

Dr. Mathieu Spriet is an Associate Professor of Diagnostic Imaging at the School of Veterinary Medicine at the University of California-Davis. In 2015, the Grayson-Jockey Club Research Foundation ...

PET scans can light up tumors in the body and help doctors determine if they are cancerous or benign (noncancerous). The results of a PET scan help guide medical decisions. A PET scan is a type of ...

SAN DIEGO--(BUSINESS WIRE)--Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small ...